A Brief Study on Type 2 Diabetes Mellitus and Benfotiamine

Science Press Release Distribution Services

A Brief Study on Type 2 Diabetes Mellitus and Benfotiamine

September 11, 2021 Health Research 0

Supplementing with benfotiamine (BFT) may help to prevent various diabetes-related vascular and neuronal complications. The mechanism by which BFT influences diabetes angiogenesis and neuropathies pathogenesis is unknown. This mini-review intended to examine the most recent information on the impact of benfotiamine (a lipid-soluble thiamine derivative with better bioavailability than thiamine) on some metabolic and functional parameters in T2DM patients with diabetic angio-, neuropathies. To confirm the beneficial effect of BFT on biochemical parameters, dynamics of independent cardiovascular tests, daily monitoring of electrocardiography, arterial wall stiffness parameters among patients with type 2 diabetes mellitus, diabetic angio-, neuropathies, and their associated comorbidities, more research is needed.

Author (S) Details

Victoria A. Serhiyenko
Department of Endocrinology, Danylo Halytsky Lviv National Medical University, Ukraine.

Alexandr A. Serhiyenko
Department of Endocrinology, Danylo Halytsky Lviv National Medical University, Ukraine.

View Book :- https://stm.bookpi.org/IDHR-V3/article/view/3306

 

Leave a Reply

Your email address will not be published. Required fields are marked *